ARCHIVES

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

This article is from The Cancer Letter archive.

Vol. 13 No. 48 | December 11, 1987

Download PDF Visit The Full Archive

Related Articles

NCAB Approves Addition Of Two New Organ Systems

February 14, 1986

NIH Panel Outlines Strategies To Manage Adrenal Tumors.

February 22, 2002

New Toxicology Protocol Works, Predicts Safe starting Doses, Saves $1 Million

June 25, 1982

ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says.

July 28, 2006

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

April 10, 1981

Trials Approved by NCI CTEP Last Month

November 25, 2011